Literature DB >> 26522749

The Role of Echocardiography in the Evaluation of Pulmonary Arterial Hypertension.

Nicole Pristera1, Ray Musarra2,3, Robert Schilz4, Brian D Hoit1,2,3.   

Abstract

The evaluation of pulmonary arterial hypertension (PAH) requires a multimodality approach that combines invasive and noninvasive imaging studies to ensure accurate diagnosis and classification. Given the complexity of the hemodynamic relationships between the left heart, pulmonary circulation, and right heart, the diagnosis of PAH is often a challenging task. Right heart catheterization is the gold standard for diagnosis, providing the hemodynamic information that defines the disease. Nonetheless, echocardiography continues to be a valuable tool in the approach to the patient with suspected PAH. Echocardiographic assessment generates a wealth of information about the response of the right heart to elevated pulmonary pressures and provides essential diagnostic and prognostic data to the clinician. Numerous measurements can be used to identify alterations in right heart morphology, pressure, and function; although each variable in isolation may have little utility, meaningful information is revealed when multiple parameters are considered together. In this article, we will review the echocardiographic measurements employed in assessment of the right heart and seek to clarify the role of echocardiography in the diagnostic workup of PAH.
© 2015, Wiley Periodicals, Inc.

Entities:  

Keywords:  echocardiography; pulmonary arterial hypertension; right ventricular function

Mesh:

Year:  2015        PMID: 26522749     DOI: 10.1111/echo.13113

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  9 in total

1.  An association between volumes of the cardiac chambers and troponin levels in individuals submitted to cardiac coronary computed tomography.

Authors:  Zach Rozenbaum; Yaron Arbel; Yoav Granot; Dotan Cohen; Haim Shmilovich; Tomer Ziv-Baran; Ehud Chorin; Ofer Havakuk; Merav Cohen; Shlomo Berliner; Yan Topilsky; Galit Aviram
Journal:  Clin Cardiol       Date:  2017-06-14       Impact factor: 2.882

2.  Lipopolysaccharide acutely suppresses right-ventricular strain in rats with pulmonary artery hypertension.

Authors:  Junjie Zhang; Yanan Cao; Xiaowei Gao; Maoen Zhu; Zhong Zhang; Yue Yang; Qulian Guo; Yonggang Peng; E Wang
Journal:  Pulm Circ       Date:  2017-12-18       Impact factor: 3.017

3.  A novel scoring index by Doppler echocardiography for predicting severe pulmonary hypertension due to chronic lung diseases: a cross-sectional diagnostic accuracy study.

Authors:  Rong Jiang; Cheng Wu; Bigyan Pudasaini; Lan Wang; Qin-Hua Zhao; Rui Zhang; Wen-Hui Wu; Ping Yuan; Zhi-Cheng Jing; Jin-Ming Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-06-14

4.  Transition from Ambrisentan to Bosentan in Pulmonary Arterial Hypertension: A Single-Center Prospective Study.

Authors:  Su-Gang Gong; Lan Wang; Bigyan Pudasaini; Ping Yuan; Rong Jiang; Qin-Hua Zhao; Jing He; Rui Zhang; Wen-Hui Wu; Jin-Ming Liu; Cai-Cun Zhou
Journal:  Can Respir J       Date:  2018-04-11       Impact factor: 2.409

5.  Is there a learning effect when the 6-minute walk test is repeated in people with suspected pulmonary hypertension?

Authors:  Lissa Spencer; Bill Zafiropoulos; Wendy Denniss; Dot Fowler; Jennifer Alison; David Celermajer
Journal:  Chron Respir Dis       Date:  2018-01-23       Impact factor: 2.444

6.  Initial ultrasound evaluation of an anterior mediastinal mass ultimately diagnosed as T-cell acute lymphoblastic leukemia: a report of three cases in children.

Authors:  Takahiro Hosokawa; Mamoru Honda; Yuki Arakawa
Journal:  Radiol Case Rep       Date:  2022-07-30

7.  A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil.

Authors:  Mariann Bombicz; Daniel Priksz; Balazs Varga; Andrea Kurucz; Attila Kertész; Akos Takacs; Aniko Posa; Rita Kiss; Zoltan Szilvassy; Bela Juhasz
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

8.  Red Blood Cell Distribution Width Predicts Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease.

Authors:  Jie Yang; Chuanmei Liu; Lingling Li; Xiongwen Tu; Zhiwei Lu
Journal:  Can Respir J       Date:  2019-07-11       Impact factor: 2.409

9.  Echocardiography Nomogram for Predicting Survival among Chronic Lung Disease Patients with Severe Pulmonary Hypertension.

Authors:  Rong Jiang; Lan Wang; Qin-Hua Zhao; Cheng Wu; Ping Yuan; Shang Wang; Rui Zhang; Su-Gang Gong; Wen-Hui Wu; Jing He; Hong-Ling Qiu; Ci-Jun Luo; Jin-Ming Liu; Zhi-Cheng Jing
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.